Table of Contents Author Guidelines Submit a Manuscript
Anesthesiology Research and Practice
Volume 2009, Article ID 827290, 9 pages
http://dx.doi.org/10.1155/2009/827290
Clinical Study

Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey

1Department of Anesthesiology, Intensive Care, Emergency Medicine and Pain Therapy, Kantonsspital Lucerne, 6000 Lucerne, Switzerland
2Department of Anesthesiology, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany
3Department of Anesthesiology and Pain Medicine, Swiss Paraplegic Center, 6207 Nottwil, Switzerland
4Department of Neuroscience, Algesiology and Pediatrics, 90419 Nuremberg, Germany

Received 20 April 2009; Revised 30 July 2009; Accepted 7 September 2009

Academic Editor: Thomas J. J. Blanck

Copyright © 2009 Janet Weber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Janet Weber, Marcus Schley, Matthias Casutt, et al., “Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey,” Anesthesiology Research and Practice, vol. 2009, Article ID 827290, 9 pages, 2009. https://doi.org/10.1155/2009/827290.